These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20233883)

  • 1. Transcriptional profiles predict disease outcome in patients with cutaneous T-cell lymphoma.
    Litvinov IV; Jones DA; Sasseville D; Kupper TS
    Clin Cancer Res; 2010 Apr; 16(7):2106-14. PubMed ID: 20233883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL).
    Litvinov IV; Netchiporouk E; Cordeiro B; Doré MA; Moreau L; Pehr K; Gilbert M; Zhou Y; Sasseville D; Kupper TS
    Clin Cancer Res; 2015 Jun; 21(12):2820-9. PubMed ID: 25779945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome.
    Shin J; Monti S; Aires DJ; Duvic M; Golub T; Jones DA; Kupper TS
    Blood; 2007 Oct; 110(8):3015-27. PubMed ID: 17638852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
    Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
    Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
    Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
    J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of cutaneous T-cell lymphoma: molecular diagnosis, pathogenesis, therapy and future directions.
    Dippel E; Klemke CD; Goerdt S
    Onkologie; 2003 Oct; 26(5):477-83. PubMed ID: 14605466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis.
    Miyagaki T; Sugaya M; Suga H; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e60-7. PubMed ID: 22404649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-Cell Profiling of Cutaneous T-Cell Lymphoma Reveals Underlying Heterogeneity Associated with Disease Progression.
    Borcherding N; Voigt AP; Liu V; Link BK; Zhang W; Jabbari A
    Clin Cancer Res; 2019 May; 25(10):2996-3005. PubMed ID: 30718356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of T-cell receptor gene rearrangement for predicting clinical outcome in patients with cutaneous T-cell lymphoma: a comparison of Southern blot and polymerase chain reaction methods.
    Juarez T; Isenhath SN; Polissar NL; Sabath DE; Wood B; Hanke D; Haycox CL; Wood GS; Olerud JE
    Arch Dermatol; 2005 Sep; 141(9):1107-13. PubMed ID: 16172307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of BCL7A expression correlates with poor disease prognosis in patients with early-stage cutaneous T-cell lymphoma.
    Litvinov IV; Zhou Y; Kupper TS; Sasseville D
    Leuk Lymphoma; 2013 Mar; 54(3):653-4. PubMed ID: 22856870
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased HMGB1 levels in lesional skin and sera in patients with cutaneous T-cell lymphoma.
    Senda N; Miyagaki T; Kamijo H; Nakajima R; Oka T; Takahashi N; Suga H; Yoshizaki A; Asano Y; Sugaya M; Sato S
    Eur J Dermatol; 2018 Oct; 28(5):621-627. PubMed ID: 30378541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-Cell Lymphocyte Heterogeneity in Advanced Cutaneous T-cell Lymphoma Skin Tumors.
    Gaydosik AM; Tabib T; Geskin LJ; Bayan CA; Conway JF; Lafyatis R; Fuschiotti P
    Clin Cancer Res; 2019 Jul; 25(14):4443-4454. PubMed ID: 31010835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA Signatures in Diagnosis and Prognosis of Cutaneous T-Cell Lymphoma.
    Shen X; Wang B; Li K; Wang L; Zhao X; Xue F; Shi R; Zheng J
    J Invest Dermatol; 2018 Sep; 138(9):2024-2032. PubMed ID: 29559342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival.
    Gjerdrum LM; Woetmann A; Odum N; Burton CM; Rossen K; Skovgaard GL; Ryder LP; Ralfkiaer E
    Leukemia; 2007 Dec; 21(12):2512-8. PubMed ID: 17713545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
    Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
    Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
    Vidulich KA; Talpur R; Bassett RL; Duvic M
    Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients.
    Zackheim HS; Amin S; Kashani-Sabet M; McMillan A
    J Am Acad Dermatol; 1999 Mar; 40(3):418-25. PubMed ID: 10071312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes.
    Laharanne E; Oumouhou N; Bonnet F; Carlotti M; Gentil C; Chevret E; Jouary T; Longy M; Vergier B; Beylot-Barry M; Merlio JP
    J Invest Dermatol; 2010 Jun; 130(6):1707-18. PubMed ID: 20130593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of AHI1 and CDKN1C in cutaneous T-cell lymphoma progression.
    Litvinov IV; Kupper TS; Sasseville D
    Exp Dermatol; 2012 Dec; 21(12):964-6. PubMed ID: 23171462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic aberrations and survival in cutaneous T cell lymphomas.
    Fischer TC; Gellrich S; Muche JM; Sherev T; Audring H; Neitzel H; Walden P; Sterry W; Tönnies H
    J Invest Dermatol; 2004 Mar; 122(3):579-86. PubMed ID: 15086538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.